Tirzepatide test results: how often vials pass lab testing
Tirzepatide is an approved drug, but the vials in these tests are not Mounjaro or Zepbound. They are tirzepatide sold online as a research chemical, and about a third of them fail.
Of the last 195 Tirzepatide samples with a result in Finnrick's public lab-testing database, 128 passed and 67 failed: 66 percent of Tirzepatide test results were a pass. Another 5 came back incomplete and are left out. Finnrick has published 2,923 Tirzepatide tests from 281 sellers since 17 Dec 2024.
Tirzepatide is FDA-approved, sold as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management. The results on this page are not about those products. They are about tirzepatide sold online with a research-use-only label, which is the same molecule on paper and a very different product in practice.
The short version
- 66 percent of recent samples passed. 128 passed and 67 failed, of the last 195 with a result.
- The molecule is FDA-approved. Mounjaro and Zepbound are the approved products. A research-labelled vial is neither.
- A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
- We do not name sellers. The numbers describe the market, not any one shop.
Tirzepatide test results in numbers
| Measure | Tirzepatide |
|---|---|
| Published tests | 2,923 |
| Sellers with at least one test | 281 |
| First and latest test | 17 Dec 2024 to 9 Nov 2026 |
| Recent results counted | 195 (5 incomplete left out) |
| Passed | 128 |
| Failed | 67 |
| Pass rate | 66% |
| Rank by pass rate | 4 of 14 on our peptide test results page |
Figures from Finnrick's public Tirzepatide page, checked on 12 November 2026. They will change as new results come in.
What counts as a pass or a fail
These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.
The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.
Is tirzepatide FDA-approved?
Yes, as Mounjaro and Zepbound (see our tirzepatide page). Compounding pharmacies were allowed to make copies while tirzepatide was on FDA's shortage list. FDA declared that shortage resolved on 19 December 2024, and the grace periods for compounders ended in February and March 2025. Our page on the compounded GLP-1 crackdown has the full timeline.
Research tirzepatide is not Zepbound
An approved pen is made under drug manufacturing rules, released against a specification and traceable by lot. A research-labelled vial carries none of that. It is a powder from a seller, and the only evidence about its contents is a test.
Of the last 195 tirzepatide samples with a result, 67 failed. Finnrick has published 2,923 tirzepatide tests from 281 sellers since 17 Dec 2024, the second most of any compound after retatrutide.
Before you buy Tirzepatide
Tirzepatide is an approved medicine, so a prescription filled by a licensed pharmacy is the safer route: the pharmacy carries the testing and the traceability. Peptide AI's prescription route through licensed telehealth is coming soon and will lead with compounds like this one.
Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.
Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.
Questions people ask
What percentage of Tirzepatide fails lab testing?
In Finnrick's public test database, 67 of the last 195 Tirzepatide samples with a result failed, which is 34 percent, and 128 passed. Tests that came back incomplete are left out.
Is Tirzepatide FDA-approved?
The molecule is FDA-approved. Mounjaro and Zepbound are the approved products. A research-labelled vial is neither.
Does a passing lab test mean Tirzepatide is safe?
No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Tirzepatide is safe or does anything in people.
Is research tirzepatide the same as Mounjaro or Zepbound?
It is sold under the same molecule name, but it is a different product. Mounjaro and Zepbound are approved drugs made under drug manufacturing rules. A research-labelled vial is not an approved drug, and 67 of the last 195 tested samples failed.
Sources
- Methodology, Finnrick, accessed 12 November 2026
- Tirzepatide product page and public test history, Finnrick, accessed 12 November 2026
